Molecular Markers in the Improvement in the Medicinal Plants

2012 ◽  
Vol 01 (02) ◽  
Author(s):  
Brijmohan Singh Bhau
2018 ◽  
Vol 26 (5) ◽  
pp. 2003-2009
Author(s):  
Samar A. Salah ◽  
Enjy M. Masoad ◽  
A. El-bakry ◽  
S.A. Ibrahim

Medicinal plants are major sources of secondary metabolites for which they have been paid more attention by pharmaceutical industries. In order to produce these secondary metabolites, medicinal plants are cultivated and for that plant tissue or organ, culture can be a suitable alternative. However, these plants are treated with plant hormones and elicitors to enhance the secondary metabolites and such elicitation may lead to genetic or epigenetic changes which are known as somaclonal variations. Thus, a stringent method of monitoring is required to observe the true-to-types of these medicinal plants when multiplied through tissue culture. Molecular markers like Randomly Amplified Polymorphic DNA (RAPD), Inter-Simple Sequence Repeat (ISSR), and Simple Sequence Repeats (SSR) are highly suitable markers to assess clonal fidelity in micropropagated medicinal plants. In the present chapter, the execution of such markers to check somaclonal variations in tissue culture raised medicinal plants is discussed in detail.


2019 ◽  
Vol 6 (4) ◽  
pp. 465-478
Author(s):  
Rubeena Mattummal ◽  
Divya Kallingilkalathil Gopi ◽  
Erni Bobbili ◽  
Sunil Kumar Koppala Narayana

Traditional medical systems are advancing to the level of modern medicines in treatment and preventive aspects. The increased trade in medicinal plants provides income source for herbalists while substitution of rare ingredients with cheaper and more readily available species is misleading the end users. The prime cause of the problems associated with the standardization of medicinal plants is complex composition of herbal drugs used in the form of whole plants, plant parts or extracts. Deliberate adulteration of intended ingredients are posing difficulty in distinguishing the genuine resources. Authentication of medicinal plants by recent molecular techniques is inevitable for herbal drug industries, researchers and academia. Of late, herbal genomics, molecular studies of medicinal plants and powerful next generation sequencing techniques have been emerged to transform the current knowledge. A compilation of various molecular markers used, their efficiency in barcoding for the purpose of accurate authentication of herbal drugs has been attempted in this study. Data were collected from previous literature and online repositories like NCBI, Pubmed etc. There are various molecular techniques that can be exploited for authentication of medicinal plants such as Restriction Fragment Length Polymorphism (RFLP), Random Amplified Polymorphic DNA (RAPD), Amplified Fragment Length Polymorphism (AFLP), Sequence Characterized Amplified Region (SCAR), Selective Amplification of Microsatellite polymorphic loci (SAMPL), Simple Sequence Repeats (SSR), Inter Simple Sequence Repeat (ISSR), DNA barcoding, Next Generation Sequencing Techniques etc. Some of medicinal plants were reported having molecular data useful in plant identification. The genomic data of poly herbal formulations helps for scientific validation and universal recognition. Even though the challenges associated with reprehensibility, primer designing, amplification products of molecular markers and troubles related with DNA isolation and purification, become the major obstacle in front of researchers. It is high time to focus these novel strategies for proper identification to ensure the fidelity of traditional herbal products and there by promoting a step towards the global acceptance of our indigenous medicinal systems.


Swiss Surgery ◽  
2001 ◽  
Vol 7 (6) ◽  
pp. 243-248
Author(s):  
Scheunemann ◽  
Hosch ◽  
Kutup ◽  
Izbicki

Die Einführung von immunhisto-/zytochemischen und molekularbiologischen bzw. zytogenetischen Methoden in der onkologische Forschung hat trotz vieler nach wie vor bestehender offener Fragen insgesamt zu einem besseren Verständnis der genetischen Ursachen der Tumorentstehung geführt. Darüber hinaus ergaben sich in verschiedenen Studien Hinweise für eine prognostische Relevanz von bestimmten (zyto)genetischen Veränderungen bzw. residualen Tumorzellen in Lymphknoten oder Knochenmark. Bevor diese Untersuchungen jedoch in den klinischen Alltag Einzug halten und therapeutische Konsequenzen abgeleitet werden können, sind weitere prospektive Studien mit groáen Patientenfallzahlen sowie vereinheitlichte und methodologisch praktikable Untersuchungstechniken zu fordern.


Planta Medica ◽  
2008 ◽  
Vol 74 (09) ◽  
Author(s):  
A Sapcanin ◽  
A Imamovic ◽  
E Kovac-Besovic ◽  
K Durić ◽  
I Tahirovic ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document